CRISPR Therapeutics AG (CRSP): Price and Financial Metrics
CRSP Price/Volume Stats
| Current price | $40.72 | 52-week high | $91.10 |
| Prev. close | $40.38 | 52-week low | $39.41 |
| Day low | $39.41 | Volume | 3,348,300 |
| Day high | $41.02 | Avg. volume | 1,522,823 |
| 50-day MA | $48.37 | Dividend yield | N/A |
| 200-day MA | $53.83 | Market Cap | 3.48B |
CRSP Stock Price Chart Interactive Chart >
CRISPR Therapeutics AG (CRSP) Company Bio
CRISPR Therapeutics AG focuses on the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 gene-editing platform. The company is based in Basel, Switzerland.
CRSP Price Returns
| 1-mo | -12.03% |
| 3-mo | -15.48% |
| 6-mo | -29.72% |
| 1-year | -36.05% |
| 3-year | -50.07% |
| 5-year | -40.01% |
| YTD | -34.95% |
| 2023 | 54.00% |
| 2022 | -46.36% |
| 2021 | -50.51% |
| 2020 | 151.39% |
| 2019 | 113.18% |
Continue Researching CRSP
Here are a few links from around the web to help you further your research on CRISPR Therapeutics AG's stock as an investment opportunity:CRISPR Therapeutics AG (CRSP) Stock Price | Nasdaq
CRISPR Therapeutics AG (CRSP) Stock Quote, History and News - Yahoo Finance
CRISPR Therapeutics AG (CRSP) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...